April 30, 2004 — An infusion of n-3 polyunsaturated fatty acids (PUFA) had immediate inhibitory effects on sustained ventricular tachycardia, according to the results of a pilot study published in the ...

In patients with treatment-refractory sustained ventricular tachycardia (VT), stereotactic arrhythmia radioablation (STAR) was associated with a substantial reduction in VT burden and implantable ...

CHICAGO -- For patients with ventricular tachycardia (VT) and ischemic cardiomyopathy, going right to catheter ablation improved outcomes compared with trying antiarrhythmic drugs first, the VANISH2 ...

A new technology using ultralow temperature cryoablation (ULTC) has eliminated clinical ventricular tachycardia (VT) in 94% of patients. The late-breaking science is presented at EHRA 2024, a ...

Please provide your email address to receive an email when new articles are posted on . Patients with scar-related ventricular tachycardia (VT) who received VT ablation plus a subcutaneous ICD had ...

Medtronic plc received U.S. FDA approval to undertake an early feasibility study of its dual-energy Affera cardiac ablation system in sustained ventricular tachycardia. Affera combines both ...

Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — Among patients with ventricular tachycardia indicated for an implantable cardioverter ...

Poor myocardial perfusion after myocardial infarction (MI) is associated with scar development and impaired left ventricular function, and might, therefore, lead to an increased risk of sustained ...

Ventricular tachycardia, or V-tach (VT), and supraventricular tachycardia (SVT) are two types of tachycardia. The term “tachycardia” refers to a heart rate of more than 100 beats per minute. The key ...

Ventricular fibrillation (VFib or VF) and ventricular tachycardia (v-tach or VT) are two types of heart arrhythmia that occur in the heart’s lower chambers called the ventricles. The ventricles ...